IXC 5.26% 7.2¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-99

  1. 8,416 Posts.
    lightbulb Created with Sketch. 1385
    I'm not aware of any example of a biotech voluntarily returning cash after winding up a trial.

    Even equity investment companies trading at well below NTA rarely voluntarily wind up.

    Anyway, IXC aren't going to even consider it until they very belatedly find out what the TAM is.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
-0.004(5.26%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.3¢ 7.3¢ 7.2¢ $2.243K 30.74K

Buyers (Bids)

No. Vol. Price($)
1 38792 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4000 1
View Market Depth
Last trade - 12.37pm 22/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.